Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Verheesen, M.R Haaft, N. Lindner, C.T Verrips, J.J.W Haard (2003)
Beneficial properties of single-domain antibody fragments for application in immunoaffinity purification and immuno-perfusion chromatography.Biochimica et biophysica acta, 1624 1-3
D Gueorguieva, S Li, N Walsh, A Mukerji, J Tanha, S Pandey (2006)
Identification of single-domain, Bax-specific intrabodies that confer resistance to mammalian cells against oxidative-stress-induced apoptosisFASEB J, 20
K. Conrath, M. Lauwereys, M. Galleni, A. Matagne, J. Frère, J. Kinne, L. Wyns, S. Muyldermans (2001)
β-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the CamelidaeAntimicrobial Agents and Chemotherapy, 45
E. Genst, K. Silence, K. Decanniere, K. Conrath, R. Loris, J. Kinne, S. Muyldermans, L. Wyns (2006)
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies.Proceedings of the National Academy of Sciences of the United States of America, 103 12
R. Linden, B. Geus, W. Stok, W. Bos, D. Wassenaar, T. Verrips, L. Frenken (2000)
Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama.Journal of immunological methods, 240 1-2
N. Pant, A. Hultberg, Yaofeng Zhao, L. Svensson, Q. Pan-Hammarstrom, K. Johansen, P. Pouwels, F. Ruggeri, P. Hermans, L. Frenken, T. Borén, H. Marcotte, Lennart Hammarstrom (2006)
Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea.The Journal of infectious diseases, 194 11
Jianbing Zhang, J. Tanha, T. Hirama, N. Khieu, R. To, Hong Tong-Sevinc, Emily Stone, J. Brisson, C. Mackenzie (2004)
Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents.Journal of molecular biology, 335 1
K. Conrath, C. Vincke, B. Stijlemans, J. Schymkowitz, K. Decanniere, L. Wyns, S. Muyldermans, R. Loris (2005)
Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH.Journal of molecular biology, 350 1
J. Davies, L. Riechmann (1996)
Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability.Protein engineering, 9 6
Dirk Saerens, J. Kinne, E. Bosmans, U. Wernery, S. Muyldermans, K. Conrath (2004)
Single Domain Antibodies Derived from Dromedary Lymph Node and Peripheral Blood Lymphocytes Sensing Conformational Variants of Prostate-specific Antigen*Journal of Biological Chemistry, 279
Katja Conrath, M. Lauwereys, L. Wyns, S. Muyldermans (2001)
Camel Single-domain Antibodies as Modular Building Units in Bispecific and Bivalent Antibody Constructs*The Journal of Biological Chemistry, 276
S. Muyldermans (2001)
Single domain camel antibodies: current status.Journal of biotechnology, 74 4
P. Holliger, P. Hudson (2005)
Engineered antibody fragments and the rise of single domainsNature Biotechnology, 23
A. Muruganandam, J. Tanha, S. Narang, D. Stanimirovic (2002)
Selection of phage‐displayed llama single‐domain antibodies that transmigrate across human blood‐brain barrier endotheliumThe FASEB Journal, 16
Lars Nieba, A. Honegger, C. Krebber, A. Plückthun (1997)
Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment.Protein engineering, 10 4
C. Hamers-Casterman, T. Atarhouch, S. Muyldermans, G. Robinson, C. Hamers, E. Songa, N. Bendahman, R. Hamers (1993)
Naturally occurring antibodies devoid of light chainsNature, 363
B Stijlemans, K Conrath, V Cortez-Retamozo, H Xong, L Wyns, P Senter, H Revets, P Baetselier, S Muyldermans, S Magez (2004)
Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigmJ Biol Chem, 279
S. Hamilton, R. Davidson, N. Sethuraman, J. Nett, Youwei Jiang, Sandra Rı́os, P. Bobrowicz, T. Stadheim, Huijuan Li, Byung‐Kwon Choi, D. Hopkins, Harry Wischnewski, Jessica Roser, T. Mitchell, R. Strawbridge, J. Hoopes, S. Wildt, T. Gerngross (2006)
Humanization of Yeast to Produce Complex Terminally Sialylated GlycoproteinsScience, 313
L. Presta (2006)
Engineering of therapeutic antibodies to minimize immunogenicity and optimize function.Advanced drug delivery reviews, 58 5-6
W. Gibson (2003)
Faculty Opinions recommendation of Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm.
A. Desmyter, T. Transue, M. Ghahroudi, M. Thi, F. Poortmans, R. Hamers, S. Muyldermans, L. Wyns (1996)
Crystal structure of a camel single-domain VH antibody fragment in complex with lysozymeNature Structural Biology, 3
L. Jespers, O. Schon, K. Famm, G. Winter (2004)
Aggregation-resistant domain antibodies selected on phage by heat denaturationNature Biotechnology, 22
S. Muyldermans, C. Cambillau, L. Wyns (2001)
Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains.Trends in biochemical sciences, 26 4
M. Harmsen, C. Solt, A. Bemmel, T. Niewold, F. Zijderveld (2006)
Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapyApplied Microbiology and Biotechnology, 72
V. Joosten, M. Roelofs, Niels Dries, T. Goosen, C. Verrips, C. Hondel, B. Lokman (2005)
Production of bifunctional proteins by Aspergillus awamori: llama variable heavy chain antibody fragment (V(HH)) R9 coupled to Arthromyces ramosus peroxidase (ARP).Journal of biotechnology, 120 4
L. Frenken, R. Linden, P. Hermans, J. Bos, R. Ruuls, B. Geus, C. Verrips (2000)
Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae.Journal of biotechnology, 78 1
Y. Thomassen, W. Meijer, L. Sierkstra, C. Verrips (2002)
Large-scale production of VHH antibody fragments by Saccharomyces cerevisiaeEnzyme and Microbial Technology, 30
Magdalena Pleschberger, Dirk Saerens, S. Weigert, U. Sleytr, S. Muyldermans, M. Sára, E. Egelseer (2004)
An S-layer heavy chain camel antibody fusion protein for generation of a nanopatterned sensing layer to detect the prostate-specific antigen by surface plasmon resonance technology.Bioconjugate chemistry, 15 3
P. Verheesen, A. Roussis, H. Haard, A. Groot, J. Stam, J. Dunnen, R. Frants, A. Verkleij, C. Verrips, S. Maarel (2006)
Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation.Biochimica et biophysica acta, 1764 8
A. Desmyter, K. Decanniere, S. Muyldermans, L. Wyns (2001)
Antigen Specificity and High Affinity Binding Provided by One Single Loop of a Camel Single-domain Antibody*The Journal of Biological Chemistry, 276
K. Coppieters, T. Dreier, K. Silence, H. Haard, M. Lauwereys, P. Casteels, E. Beirnaert, H. Jonckheere, C. Wiele, L. Staelens, J. Hostens, H. Revets, E. Remaut, D. Elewaut, P. Rottiers (2006)
Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis.Arthritis and rheumatism, 54 6
I. Lange, A. Daxenberger, H. Meyer (2001)
Studies on the antibody response of Lama glama--evaluation of the binding capacity of different IgG subtypes in ELISAs for clenbuterol and BSA.Veterinary immunology and immunopathology, 83 1-2
A. Nowakowski, C. Wang, D. Powers, P. Amersdorfer, Thomas Smith, V. Montgomery, Robert Sheridan, R. Blake, Leonard Smith, J. Marks (2002)
Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibodyProceedings of the National Academy of Sciences of the United States of America, 99
R. Janssens, S. Dekker, R. Hendriks, G. Panayotou, A. Remoortere, John San, F. Grosveld, D. Drabek (2006)
Generation of heavy-chain-only antibodies in miceProceedings of the National Academy of Sciences, 103
Renske Linden, L. Frenken, B. Geus, M. Harmsen, R. Ruuls, W. Stok, L. Ron, S. Wilson, P. Davis, C. Verrips (1999)
Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies.Biochimica et biophysica acta, 1431 1
Khoa Vu, M. Ghahroudi, L. Wyns, S. Muyldermans (1997)
Comparison of llama VH sequences from conventional and heavy chain antibodies.Molecular immunology, 34 16-17
M. Harmsen, C. Solt, H. Fijten, L. Keulen, Rodney Rosalia, K. Weerdmeester, A. Cornelissen, M. Bruin, P. Eblé, A. Dekker (2007)
Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease.Veterinary microbiology, 120 3-4
D. Simmons, Fiona Abregu, U. Krishnan, D. Proll, V. Streltsov, Larissa Doughty, M. Hattarki, S. Nuttall (2006)
Dimerisation strategies for shark IgNAR single domain antibody fragments.Journal of immunological methods, 315 1-2
C. Bond, J. Marsters, S. Sidhu (2003)
Contributions of CDR3 to V H H domain stability and the design of monobody scaffolds for naive antibody libraries.Journal of molecular biology, 332 3
C. Krüger, A. Hultberg, H. Marcotte, P. Hermans, S. Bezemer, L. Frenken, L. Hammarström (2006)
Therapeutic effect of llama derived VHH fragments against Streptococcus mutans on the development of dental cariesApplied Microbiology and Biotechnology, 72
J. Vaart, N. Pant, D. Wolvers, S. Bezemer, P. Hermans, K. Bellamy, S. Sarker, C. Logt, L. Svensson, C. Verrips, Lennart Hammarstrom, B. Klinken (2006)
Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments.Vaccine, 24 19
P. Dufner, L. Jermutus, R. Minter (2006)
Harnessing phage and ribosome display for antibody optimisation.Trends in biotechnology, 24 11
M. Lauwereys, M. Ghahroudi, A. Desmyter, J. Kinne, Wolfgang Hölzer, E. Genst, L. Wyns, S. Muyldermans (1998)
Potent enzyme inhibitors derived from dromedary heavy‐chain antibodiesThe EMBO Journal, 17
M. Arbabi-Ghahroudi, J. Tanha, R. MacKenzie (2005)
Prokaryotic expression of antibodiesCancer and Metastasis Reviews, 24
F. Rahbarizadeh, M. Rasaee, Mehdi forouzandeh-moghadam, A. Allameh (2005)
High expression and purification of the recombinant camelid anti-MUC1 single domain antibodies in Escherichia coli.Protein expression and purification, 44 1
M. Whitlow, B. Bell, S. Feng, D. Filpula, K. Hardman, Steven Hubert, M. Rollence, J. Wood, M. Schott, D. Milenic, T. Yokota, J. Schlom (1993)
An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability.Protein engineering, 6 8
R. Harrison, S. Hasson, M. Harmsen, G. Laing, K. Conrath, R. Theakston (2006)
Neutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid sera.Toxicon : official journal of the International Society on Toxinology, 47 3
J. Vaart (2002)
Expression of VHH antibody fragments in Saccharomyces cerevisiae.Methods in molecular biology, 178
V. Cortez-Retamozo, Natalija Backmann, P. Senter, U. Wernery, P. Baetselier, S. Muyldermans, H. Revets (2004)
Efficient cancer therapy with a nanobody-based conjugate.Cancer research, 64 8
A. Greenberg, D. Avila, M. Hughes, A. Hughes, E. McKinney, M. Flajnik (1995)
A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharksNature, 374
The FASEB Journal • FJ Express Full-Length Article Identification of single-domain, Bax-specific intrabodies
M. Dumoulin, A. Last, A. Desmyter, K. Decanniere, D. Canet, G. Larsson, A. Spencer, D. Archer, J. Sasse, S. Muyldermans, L. Wyns, C. Redfield, A. Matagne, C. Robinson, C. Dobson (2003)
A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozymeNature, 424
T. Gerngross (2004)
Advances in the production of human therapeutic proteins in yeasts and filamentous fungiNature Biotechnology, 22
Suzanne Hermeling, D. Crommelin, H. Schellekens, W. Jiskoot (2004)
Structure-Immunogenicity Relationships of Therapeutic ProteinsPharmaceutical Research, 21
F. Rahbarizadeh, M. Rasaee, M. Forouzandeh, A. Allameh (2006)
Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris.Molecular immunology, 43 5
M. Harmsen, C. Solt, H. Fijten, M. Setten (2005)
Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins.Vaccine, 23 41
P. Holliger, M. Wing, J. Pound, H. Bohlen, G. Winter (1997)
Retargeting serum immunoglobulin with bispecific diabodiesNature Biotechnology, 15
E. Goldman, G. Anderson, Jinny Liu, J. Delehanty, L. Sherwood, Lisa Osborn, L. Cummins, A. Hayhurst (2006)
Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library.Analytical chemistry, 78 24
U. Rothbauer, Kourosh Zolghadr, S. Tillib, Danny Nowak, L. Schermelleh, A. Gahl, Natalija Backmann, K. Conrath, S. Muyldermans, M. Cardoso, H. Leonhardt (2006)
Targeting and tracing antigens in live cells with fluorescent nanobodiesNature Methods, 3
R. Glockshuber, M. Malia, I. Pfitzinger, A. Plueckthun (1990)
A comparison of strategies to stabilize immunoglobulin Fv-fragments.Biochemistry, 29 6
J. Reichert, V. Valge-Archer (2007)
Development trends for monoclonal antibody cancer therapeuticsNature Reviews Drug Discovery, 6
Y. Thomassen, A. Verkleij, J. Boonstra, C. Verrips (2005)
Specific production rate of VHH antibody fragments by Saccharomyces cerevisiae is correlated with growth rate, independent of nutrient limitation.Journal of biotechnology, 118 3
V. Streltsov, J. Varghese, J. Carmichael, R. Irving, P. Hudson, S. Nuttall (2004)
Structural evidence for evolution of shark Ig new antigen receptor variable domain antibodies from a cell-surface receptor.Proceedings of the National Academy of Sciences of the United States of America, 101 34
J. Davies, L. Riechmann (1995)
Antibody VH Domains as Small Recognition UnitsBio/Technology, 13
H. Revets, P. Baetselier, S. Muyldermans (2005)
Nanobodies as novel agents for cancer therapyExpert Opinion on Biological Therapy, 5
T. Yoo, O. Roholt, D. Pressman (1967)
Specific Binding Activity of Isolated Light Chains of AntibodiesScience, 157
S. Utsumi, F. Karush (1964)
THE SUBUNITS OF PURIFIED RABBIT ANTIBODY.Biochemistry, 3
(2006)
Adapting industry practices for the rapid, large-scale manufacture of pharmaceutical proteins
J. Perez, Jean‐Guillaume Renisio, J. Prompers, CJ Platerink, C. Cambillau, H. Darbon, Lgj Frenken (2001)
Thermal unfolding of a llama antibody fragment: a two-state reversible process.Biochemistry, 40 1
JM Vaart (2002)
Methods in molecular biology, vol 178. Antibody phage display: methods and protocols
M. Zwick, P. Parren, E. Saphire, S. Church, Meng Wang, Jamie Scott, P. Dawson, I. Wilson, D. Burton (2003)
Molecular Features of the Broadly Neutralizing Immunoglobulin G1 b12 Required for Recognition of Human Immunodeficiency Virus Type 1 gp120Journal of Virology, 77
R. Aitken (2009)
Antibody phage display : methods and protocols
S. Muyldermans, T. Atarhouch, J. Saldanha, J. Barbosa, R. Hamers (1994)
Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains.Protein engineering, 7 9
Teun Laar, C. Visser, M. Holster, C. López, Dennes Kreuning, Laurens Sierkstra, N. Lindner, T. Verrips (2007)
Increased heterologous protein production by Saccharomyces cerevisiae growing on ethanol as sole carbon sourceBiotechnology and Bioengineering, 96
M. Dumoulin, K. Conrath, Annemieke Meirhaeghe, F. Meersman, K. Heremans, L. Frenken, S. Muyldermans, L. Wyns, A. Matagne (2002)
Single‐domain antibody fragments with high conformational stabilityProtein Science, 11
V. Nguyen, R. Hamers, L. Wyns, S. Muyldermans (2000)
Camel heavy‐chain antibodies: diverse germline VHH and specific mechanisms enlarge the antigen‐binding repertoireThe EMBO Journal, 19
(2007)
Appl Microbiol Biotechnol
N. Sethuraman, T. Stadheim (2006)
Challenges in therapeutic glycoprotein production.Current opinion in biotechnology, 17 4
T. Baral, S. Magez, B. Stijlemans, K. Conrath, B. Vanhollebeke, E. Pays, S. Muyldermans, P. Baetselier (2006)
Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factorNature Medicine, 12
E. Dolk, Marcel Vaart, D. Hulsik, G. Vriend, H. Haard, S. Spinelli, C. Cambillau, L. Frenken, T. Verrips (2005)
Isolation of Llama Antibody Fragments for Prevention of Dandruff by Phage Display in ShampooApplied and Environmental Microbiology, 71
M. Khattabi, H. Adams, E. Heezius, P. Hermans, F. Detmers, B. Maassen, P. Ley, J. Tommassen, T. Verrips, J. Stam (2006)
Llama Single-Chain Antibody That Blocks Lipopolysaccharide Binding and Signaling: Prospects for Therapeutic ApplicationsClinical and Vaccine Immunology, 13
J. Tanha, G. Dubuc, T. Hirama, Saran Narang, C. Mackenzie (2002)
Selection by phage display of llama conventional V(H) fragments with heavy chain antibody V(H)H properties.Journal of immunological methods, 263 1-2
C. Sagt, B. Kleizen, R. Verwaal, M. Jong, W. Müller, A. Smits, C. Visser, J. Boonstra, A. Verkleij, C. Verrips (2000)
Introduction of an N-Glycosylation Site Increases Secretion of Heterologous Proteins in YeastsApplied and Environmental Microbiology, 66
R. Linden, B. Geus, L. Frenken, H. Peters, C. Verrips (2000)
Improved production and function of llama heavy chain antibody fragments by molecular evolution.Journal of biotechnology, 80 3
Nidia Alvarez-Rueda, G. Béhar, V. Ferré, M. Pugnière, F. Roquet, L. Gastinel, C. Jacquot, J. Aubry, D. Baty, J. Barbet, S. Birklé (2007)
Generation of llama single-domain antibodies against methotrexate, a prototypical hapten.Molecular immunology, 44 7
M. Harmsen, R. Ruuls, I. Nijman, T. Niewold, L. Frenken, B. Geus (2000)
Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features.Molecular immunology, 37 10
E. Sundberg, R. Mariuzza (2002)
Molecular recognition in antibody-antigen complexes.Advances in protein chemistry, 61
V. Cortez-Retamozo, M. Lauwereys, Gholamreza Gh., Martine Gobert, K. Conrath, S. Muyldermans, P. Baetselier, H. Revets (2002)
Efficient tumor targeting by single‐domain antibody fragments of camelsInternational Journal of Cancer, 98
A. Davies (1995)
“Baculophage:” A new tool for protein displayBio/Technology, 13
S. Spinelli, L. Frenken, D. Bourgeois, L. Ron, W. Bos, T. Verrips, C. Anguille, C. Cambillau, Marietta Tegoni1 (1996)
The crystal structure of a llama heavy chain variable domainNature Structural Biology, 3
R. Roovers, T. Laeremans, Lieven Huang, Severine Taeye, A. Verkleij, H. Revets, Hans Haard, P. Henegouwen (2007)
Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR NanobodiesCancer Immunology, Immunotherapy, 56
K. Yau, Maria Groves, Shenghua Li, C. Sheedy, Hung Lee, J. Tanha, C. Mackenzie, L. Jermutus, J. Hall (2003)
Selection of hapten-specific single-domain antibodies from a non-immunized llama ribosome display library.Journal of immunological methods, 281 1-2
B. Stijlemans, K. Conrath, V. Cortez-Retamozo, Hoang Xong, L. Wyns, P. Senter, H. Revets, P. Baetselier, S. Muyldermans, S. Magez (2004)
Efficient Targeting of Conserved Cryptic Epitopes of Infectious Agents by Single Domain AntibodiesJournal of Biological Chemistry, 279
A. Olichon, D. Schweizer, S. Muyldermans, Ario Marco (2007)
Heating as a rapid purification method for recovering correctly-folded thermotolerant VH and VHH domainsBMC Biotechnology, 7
V. Nguyen, X. Zou, M. Lauwereys, L. Brys, M. Brüggemann, S. Muyldermans (2003)
Heavy‐chain only antibodies derived from dromedary are secreted and displayed by mouse B cellsImmunology, 109
E. Ward, D. Güssow, A. Griffiths, Peter Jones, G. Winter (1989)
Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coliNature, 341
S. Ewert, C. Cambillau, K. Conrath, A. Plückthun (2002)
Biophysical properties of camelid V(HH) domains compared to those of human V(H)3 domains.Biochemistry, 41 11
A. Lesk, C. Chothia (1988)
Elbow motion in the immunoglobulins involves a molecular ball-and-socket jointNature, 335
S. Spinelli, L. Frenken, P. Hermans, T. Verrips, K. Brown, M. Tegoni, C. Cambillau (2000)
Camelid heavy-chain variable domains provide efficient combining sites to haptens.Biochemistry, 39 6
M. Harmsen, C. Solt, A. Hoogendoorn, F. Zijderveld, T. Niewold, J. Meulen (2005)
Escherichia coli F4 fimbriae specific llama single-domain antibody fragments effectively inhibit bacterial adhesion in vitro but poorly protect against diarrhoea.Veterinary microbiology, 111 1-2
M. Ghahroudi, A. Desmyter, L. Wyns, R. Hamers, S. Muyldermans (1997)
Selection and identification of single domain antibody fragments from camel heavy‐chain antibodiesFEBS Letters, 414
Camelids produce functional antibodies devoid of light chains of which the single N-terminal domain is fully capable of antigen binding. These single-domain antibody fragments (VHHs or Nanobodies®) have several advantages for biotechnological applications. They are well expressed in microorganisms and have a high stability and solubility. Furthermore, they are well suited for construction of larger molecules and selection systems such as phage, yeast, or ribosome display. This minireview offers an overview of (1) their properties as compared to conventional antibodies, (2) their production in microorganisms, with a focus on yeasts, and (3) their therapeutic applications.
Applied Microbiology and Biotechnology – Springer Journals
Published: Aug 18, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.